Advanced urothelial carcinoma: Expert guidance to navigate an evolving therapeutic landscape

touchEXPERT OPINIONS for touchONCOLOGY In this activity, Prof. Thomas Powles, an oncologist specializing in bladder cancer, provides an update on the latest developments in the treatment of advanced urothelial carcinoma, including the latest guideline recommendations, supporting clinical data and factors to support decision making in clinical practice. The expert Prof. Thomas Powles, Barts Cancer Centre, London, UK This touchPODCAST is for HCPs outside of the UK and USA only. This activity is jointly funded by an independent medical education grant from Astellas Pharma Inc. and Seagen Inc. This activity is jointly provided by USF Health and touchIME. For further information visit our website:  https://touchoncologyime.org/advanced-urothelial-carcinoma-expert-guidance-to-navigate-an-evolving-therapeutic-landscape